Primary Venture Partners

📣📣 Enterprise SaaS network, activate!!📣📣 I'm thrilled to have MULTIPLE roles to share for our Primary Venture Partners' GTM role of the week, all with our breakout portfolio company Lyric, which is using AI to invent a new era of supply chain decision science. If you read the news, you know the BRITTLE reality of global supply chains. Companies big and small face complex supply chain decisions day in and day out, and Lyric has reinvented the way these teams can model out complex predictions, decisions, optimizations and everything in between... and do so EASILY. 🚀🚀🚀 I had the immense privilege of leading Lyric's first round 15 months ago, and their growth in the time since has been absolutely explosive. It is rare to find an early-stage company that is successfully working with MULTIPLE Fortune 1000 companies, but Lyric has managed to do it. 🚀🚀🚀   Lyric will be rapidly growing its team across all functions in the coming months, but right now two roles are particularly top of mind: 💰 Enterprise Account Executives. Lyric is an ROI-rich, high ACV product that should be an experienced enterprise AE's dream to sell. Competitive candidates MUST have proven track records (evidence of multiple years of quota over-achievement, etc.) selling technically complex products in multi-threaded enterprise cycles. No exceptions. https://lnkd.in/eQ76RvhA 📈 Head of Demand Generation. As Lyric further accelerates its growth, we're looking for a world-class ABM marketer to join the team to help build the company's demand gen engine. Qualified candidates will have multiple examples of building high-impact ABM campaigns from 0-1, and should have experience building multi-threaded programs for the Fortune 1000. https://lnkd.in/eJ2db7Ui This is a really special team and a truly unique breakout business. The joke in my household is that I finish many of my weeks/Friday nights on the phone with Lyric's founder/CEO Ganesh Ramakrishna, who is a force of nature in the best possible way. It's a treat to close my weeks this way, because Ganesh makes me want to go sell software again!!

Bryce Johnson has been named one of TechCrunch’s New York’s top VCs under 30. This recognition highlights the rising stars in venture capital who are already making their mark and shaping the future of the industry in NYC. Congrats, Bryce! https://lnkd.in/gAASmn2E

Excited to host the Contech Alliance on October 23rd where we'll be diving into the future of the industry with the Associate Commissioner of the NYC DDC, Oracles AI product leader for the Built World and Gryps Co-Founder Amir Tasbihi. Register for the event below to join leading developers, owners, construction companies and startups https://lu.ma/y74zh8od

🚨🚨We're baa-aack! I'm excited to share that our next "On the Business" mastery day for senior women in SaaS will take place in NYC on Monday, November 4 🚨🚨 💡Real talk: many women struggle to land and/or excel in the C-Suite because they spend too much time working IN the business versus ON the business. They manage their own functional lanes well, but often under-index on the 1) P&L command and 2) “First Team” working style required to crush it. Primary Venture Partners is committed to changing this narrative with our “On the Business” mastery series for female executives (VP- or C-Suite only) at B2B SaaS companies💡 We hosted our inaugural On the Business event a year ago and following incredible feedback, have been running quarterly programs to continue the momentum. These events have been phenomenal because of the quality of the women who've joined us; to date we've reached 375 women at companies that run the gamut from Series A startups to public companies. For our final installment of 2024, we're excited to announce a truly cross-functional program that deep dives into the metrics that matter for each functional area and more specifically, how those ladder up into a cohesive annual operating and financial plan. This is an invite-only, in-person event in Manhattan and is free to attend if your application is accepted (attendance will be capped at 150). Here's what to expect... 💁♀️ Yours Truly will offer a deep look at what SaaS leaders need to know coming into 2025, both in the market and specific to their board plans 💰 Michaela Lehr, CFO at ActionIQ and an On the Business fan-favorite, will lead a session on how to partner with your finance time to build a cohesive annual financial plan 💲Emmanuelle Skala, former SVP Customer Success and GM at Toast, will offer a perspective on how to embrace a GM mindset in the customer success function 🖱 Kristen Habacht, CRO at Typeform, will bring some product-led growth ("PLG") expertise to the house with a session that dives deep on how operating plans differ for PLG companies versus traditional sales-led businesses  ⭐ Rebecca Price, my partner at Primary Venture Partners and former CPO of Capsule, Enigma and Sailthru, will school us all into how to effectively work your PEOPLE strategy and needs into your operating plan ⌨ Neetu R., CEO at Lilac Software and former CTO at Oscar Health and Conductor, will lead a session on how Product and Engineering leaders can better align their work to the P&L and business outcomes 🥇 Lisa Lewin, my partner at Primary and former CEO of General Assembly, will lead an inspiring fireside chat with Emmanuelle and Kristen on growing and expanding your influence in the C-Suite and accelerating your path to CEO and board roles 📝 VP- AND C-LEVEL WOMEN, APPLY HERE BY EOD FRIDAY 10/11 📝 https://lnkd.in/eJUApPVH

New Jersey healthcare is about to change dramatically. Today, Hackensack Meridian Health announced its partnership with K Health to launch HMH 24/7, a new AI-driven solution that connects patients to primary care through a seamless integration of virtual and in-person care.  K Health is known for its innovative, proven solutions for scaling primary care with AI with leading health systems, including Cedars-Sinai.  K Health’s platform includes a medical chat. HMH 24/7 arrives at a perfect time as New Jersey grapples with a projected shortage of 2,800 primary care physicians by 2030.  “Our partnership with K Health couldn’t be coming at a better time, as the clear shift in primary care is uncovering the need for hybrid models that seamlessly connect virtual and in-person care across the care continuum,” said Robert C. Garrett, CEO at Hackensack Meridian Health. “We know patients want virtual care, but understanding how to deliver that in the context of a larger health system is where HMH 24/7 stands us apart.” Visit: https://lnkd.in/gGPY4c-N to learn more. https://lnkd.in/gGD8R6ip

Initially, PBMs aimed to make pharmacy claims processing less of a hassle. Gone were the days of shoeboxes full of receipts. Instead, they brought in electronic systems to streamline the process. PBMs leveraged bank identification numbers to modernize prescription workflows. The goal? To manage the vast number of prescriptions efficiently. While it began as a way to simplify prescription management, the role of PBMs has evolved into a complex system of price negotiation and cost reconciliation. Curious about how this all fits together? Dive into the full story featuring this serial healthcare entrepreneur. Link in the comments.

In Q3 2024, the NYC seed funding landscape saw a strategic pivot. While total funding dropped 13%, the average round size rose by 11%, signaling a high-conviction, low-volume approach from investors. Healthtech, AI, and FinTech deals led the way, with notable growth in transactions within the $6M-$10M range. Explore these evolving trends with industry experts Tobias Citron, Zach Fredericks, Bryce Johnson, Gaby Lorenzi, Gabriella Monico, and Rachel Pavey in Primary's Q3 NYC Seed Report. https://lnkd.in/gTd4X3qS

Who really calls the shots at a PBM? It’s not the execs or even the section heads running the rebate, network, or underwriting teams. At the end of the day, it’s the shareholders. Publicly traded PBMs have one key priority: maximizing profits every quarter—and that’s where things get messy. This healthcare founder, with a company valued at over $1 billion, insists that a PBM’s business model is built to keep investors happy, not to serve patients. Shareholder pressure keeps growing, pushing PBMs to focus on profits over people. In this chat hosted by Sam Toole, Partner at Primary, our confidential source dives into how PBMs are driving up drug prices. Link to the full conversation in the comments.

Jason Shuman and Bryce Johnson are back with their AMA series. Join them on Tuesday, October 8th at 6 pm for an interactive session where founders, operators, and aspiring VCs can dive into the world of venture capital and fundraising. RSVP here: https://lu.ma/4a4rysr6

Gabriella Monico and I have spent the last year in over 100 meetings with developers, VPs of construction, engineering firms, architects and more. Sharing our thoughts regarding vertical AI in the real estate development world and where people should really be spending time!